Aeon Global Health's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Aeon Global Health (AGHC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Aeon Global Health vs Its Competitors
- TTM: Trailing 12-month revenue of 14M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-10.7% annualized vs trailing 12 months).
- Peer revenue share: Aeon Global Health accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
AGHC Sales vs. its Competitors, Q4 2019
Aeon Global Health generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Medical Laboratories industry grew revenue 5.7% year over year, combined, vs -8.9% for Aeon Global Health. Aeon Global Health's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.